WARREN PHARMACEUTICALS INC has a total of 30 patent applications. Its first patent ever was published in 2003. It filed its patents most often in China, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are SIMU TRADE CONSULTING GMBH & CO LEASING KG, ABBOTT LAB BERMUDA LTD and LEUKOLECT AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | Brazil | 3 | |
#3 | Canada | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Mexico | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | EAPO (Eurasian Patent Organization) | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | Iceland | 2 | |
#10 | Norway | 2 | |
#11 | South Africa | 2 | |
#12 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Object sterilising | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Cerami Anthony | 22 |
#2 | Brines Michael | 22 |
#3 | Smart John | 12 |
#4 | Cerami Carla | 11 |
#5 | Coleman Thomas | 10 |
#6 | Yilmaz Osman | 7 |
#7 | Anthony Cerami | 3 |
#8 | Michael Brines | 3 |
#9 | Carla Cerami Anthony Smart Joh | 2 |
#10 | John Smart | 2 |
Publication | Filing date | Title |
---|---|---|
WO2009094202A1 | Method of treating cancer, neoplastic disorders, and symptoms thereof with compounds | |
EP1670492A2 | Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions | |
KR20060132803A | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin | |
AU2004260543A1 | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin | |
CN1882355A | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin | |
EP1545586A2 | Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |